Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lighter You vs Remote Pharmacy

Lighter You
Graded #67

Higher grade

vs+4.4
Remote Pharmacy
Graded #120

Lower grade

The verdict

Lighter You takes it — 74.3/100 to 69.9/100.

Lighter You grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lighter You advertises tirzepatide at $169 a month and charges $339 per four weeks for it in its own store, a gap of roughly two to one on the same brand.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRemote Pharmacy +7
69
76
Dose & formulationRemote Pharmacy +8
75
83
Clinical oversightLighter You +4
70
66
Labs & monitoringLighter You +19
71
52
FulfillmentLighter You +18
88
70
Contract termsLighter You +24
85
61
Lighter You · left barRemote Pharmacy · right bar

The numbers

MetricLighter YouRemote Pharmacy
WeighScore74.3/10069.9/100
GradeCC
Scorecard rank#67#120
Semaglutide$169 per 4 weeks (store and intake price; thirteen charges a year)$167/mo (all doses, compounded)
Tirzepatide$339 per 4 weeks (store and intake price; the marketing site advertises $169)$230/mo (all doses, compounded)
CoverageAll 50 states plus Washington, D.C. (claimed; the footer says otherwise)Coverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Lighter You

Graded #67 · C

Strengths

  • The store and the intake agree with each other, so a reader who starts at the store sees the figure that will be charged
  • Names four dispensing pharmacies with addresses and phone numbers
  • Runs oral, microdose and injectable GLP-1 lines plus a separate peptide sub-brand, so the menu is unusually wide for the price band
  • Unlimited video visits and dietitian check-ins are described as included in every plan
  • A full refund is offered if a clinician declines the prescription

Where it loses points

  • Tirzepatide is advertised at $169 a month on the marketing site and sold at $339 per four weeks in the store and the intake
  • The marketing site says “/mo” and the store bills per four weeks, which is thirteen charges a year rather than twelve
  • GLP-1 tablets are advertised at $249 and sold at $279 per four weeks; microdosing is advertised at $96 and sold at $179
  • The peptide sub-brand prices the same products differently again — NAD+ at $199 against $229, sermorelin at $175 against $229
  • The Terms claim all 50 states plus Washington, D.C. and the footer on the same site says not available in all 50 states
  • No clinician, medical group or NPI is named, and no compounding class appears anywhere on the domain
  • A dietitian visit is promised on the homepage with an asterisk that resolves to no footnote, and neither the Terms nor the refund policy promises one
Remote Pharmacy

Graded #120 · C

Strengths

  • Low cash-pay pricing with no subscription or hidden fees
  • Free doctor consultation and free shipping (you pay only for medication)
  • Offers injectable and sublingual or tablet forms of both drugs
  • Medication made by 503A-certified compounding facilities

Where it loses points

  • Does not publicly name its specific compounding pharmacies or clinical provider
  • Covered states are not listed on the pages reviewed
  • Newer brand with limited third-party track record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard